EcoDrugPlus

Cyclin Dependent Kinase 2

Ensembl ID : ENSDCDG00000033226
Gene Symbol: CDK2
3 Cross references
203 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSDCDG00000034415
Gene Symbol: CDK4
3 Cross references
239 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSDCDG00000016883
Gene Symbol: CDK5
3 Cross references
168 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSDCDG00000034093
Gene Symbol: CDK6
3 Cross references
200 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSDCDG00000018040
Gene Symbol: CDK7
3 Cross references
219 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSDCDG00000029739
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSDCDG00000007732
Gene Symbol: CDK1
1 Cross references
245 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSDCDG00000030381
Gene Symbol: LOC114774351
3 Cross references
245 Possible Orthologues:

Cyclin-Dependent-Like Kinase 5

Ensembl ID : ENSDCDG00000011748
Gene Symbol: LOC114775946
3 Cross references
168 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1-Like

Ensembl ID : ENSDCDG00000021715
Gene Symbol: LOC114768303
3 Cross references
177 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSDCDG00000031811
Gene Symbol: CDA
3 Cross references
197 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSDCDG00000030541
Gene Symbol: CDA
3 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).